ACRS icon

Aclaris Therapeutics (ACRS)

NASDAQ

$4.54

-$0.0100 (

-0.22%

)

1D
5D
1M
6M
1Y
5Y
Pre market

ACRS: $4.54 / ₿ 0.0001 BTC / 5872 Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$4.55
$1.22 - $5.15
$634.07M
1.03
$1,088.00
139.66M
$4.22 - $4.66
Yes

What is Aclaris Therapeutics (ACRS)?

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company. It focuses on developing novel drug candidates for immuno-inflammatory diseases using its proprietary KINect drug discovery platform. The company's pipeline consists of the following key product candidates: Bosakitug (ATI-045), an investigational, novel, humanized anti-TSLP monoclonal antibody being developed for patients with severe asthma, COPD, and chronic rhinosinusitis with nasal polyps; ATI-2138, being developed for the potential treatment of T cell-mediated autoimmune diseases; and ATI-052 and ATI-9494. Additionally, it has an investigational product candidate, Lepzacitinib (ATI-1777), which is being focused upon as a potential treatment for atopic dermatitis and potentially other dermatologic conditions.

The Aclaris Therapeutics (ACRS) stock price has been falling

The Aclaris Therapeutics, Inc. Common Stock (ACRS) stock pre-market price today is $4.54, reflecting a -0.22% pre-market move since the market last closed. The company’s market capitalization stands at $634.07M, with a daily trading volume of $1.09K shares. The previous closing price was $4.55.

Get started with Aclaris Therapeutics (ACRS)

Ready to get started? Follow the steps below, or read our guide on how to buy Aclaris Therapeutics stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy ACRS

Search for ACRS in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy ACRS.

ACRS FAQs

ACRS is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

ACRS is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, Aclaris Therapeutics, Inc. Common Stock (ACRS) has traded between a low of $1.22 and a high of $5.15.

ACRS is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in Aclaris Therapeutics? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
ACRS icon
ACRS

Only available to USA clients through the Kraken app
or Kraken Pro.

Explore other stocks

Most active

Explore the most-traded stocks today

Top gainers

Browse today’s biggest stock market winners

YHNAR icon

YHNAR

PCLA icon

PCLA

ALVOW icon

ALVOW

LFS icon

Top losers

Compare the worst-performing stocks of 
the day

YOTAR icon

YOTAR

ARQQW icon
NGEN icon
HUBCW icon

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.